NCAM1 and sarcopenia: This study's timeline, marked by increasing Type I and II NCAM+ myofibre populations, followed by selective myofibre atrophy and emergence of multi‐MyHC type myofibres, points to early muscle innervation impairment leading to sarcopenia in PS19 mice.